Evidence map›Paper›PMID 40856523›Full record

ArticleBriefings in bioinformatics2025

ProDualNet: dual-target protein sequence design method based on protein language model and structure model.

Liu Cheng, Ting Wei, Xiaochen Cui, Hai-Feng Chen, Zhangsheng Yu

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liu ChengDepartment of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Ting WeiDepartment of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Xiaochen CuiIntelligent Medicine Original (Shanghai) Co., Ltd., Shanghai, China.
Hai-Feng ChenDepartment of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.ORCID 0000-0002-7496-4182
Zhangsheng YuDepartment of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.ORCID 0000-0002-8189-5330

Funding

Medical Engineering Cross Fund of Shanghai Jiao Tong University YG2023ZD21National Key Research and Development Program of China 2023YFF1205102National Key Research and Development Program of China 2025YFA0921001National Natural Science Foundation of China 12171318National Natural Science Foundation of China 32171242Shanghai Municipal Science and Technology Major ProjectShanghai Science and Technology Commission 21ZR1436300Shanghai Science and Technology Commission 23DZ2290600Shanghai Science and Technology Commission 23XD1401900Shanghai Science and Technology Commission 24JS2810200Shanghai Science and Technology Commission YG2023LC03SJTU Kunpeng & Ascend Center of Excellence, the Center for HPC at Shanghai Jiao Tong University
6 · The paper itself

Abstract

Proteins typically interact with multiple partners to regulate biological processes, and peptide drugs targeting multiple receptors have shown strong therapeutic potential, emphasizing the need for multi-target strategies in protein design. However, most current protein sequence design methods focus on interactions with a single receptor, often neglecting the complexity of designing proteins that can bind to two distinct receptors. We introduced Protein Dual-Target Design Network (ProDualNet), a structure-based sequence design method that integrates sequence-structure information from two receptors to design dual-target protein sequences. ProDualNet used a heterogeneous graph network for pretraining and combines noise-augmented single-target data with real dual-target data for fine-tuning. This approach addressed the challenge of limited dual-target protein experimental structures. The efficacy of ProDualNet has been validated across multiple test sets, demonstrating better recovery and success rates compared to other multi-state design methods. In silico evaluation of cases like dual-target allosteric binding and non-overlapping interface binding highlights its potential for designing dual-target binding proteins. Data and code are available at https://github.com/chengliu97/ProDualNet.

Indexed as

Computational BiologyModels, MolecularProteinsSoftwareAlgorithmsAmino Acid SequenceHumansProtein BindingProtein ConformationProteinsdual-target protein sequence designprotein sequence designstructure-based protein sequence design

Identifiers

PMID40856523
PMCPMC12378908

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.